Vivian Walkowski

Vivian Walkowski is a seasoned tech writer with over 15 years of industry experience. She holds a Bachelor of Science in Computer Science from The William Marsh Rice University where her passion for technology and writing was first ignited. Prior to her writing career, Vivian worked as a senior software engineer at Kearsley Compute INC, a renowned Silicon Valley tech firm, where she refined her deep understanding of technological innovation and trends. In her writing, Vivian strives to bridge the gap between complex tech concepts and the average reader, offering accessible and insightful commentary on the latest technological developments. In addition to three technical books, her articles have appeared in leading tech publications, setting her as an influential voice in the tech space.

Microfluidic Organ-on-Chip Engineering 2025: Revolutionizing Drug Discovery & Disease Modeling with 18% CAGR Growth

Microfluidic Organ-on-Chip Engineering 2025: Revolutionizing Drug Discovery & Disease Modeling with 18% CAGR Growth

Microfluidic Organ-on-Chip Engineering in 2025: Transforming Biomedical Research and Accelerating Personalized Medicine. Explore the Breakthroughs, Market Dynamics, and Future Trajectory of This Disruptive Technology. Executive Summary: Key Insights and Market Highlights Market Overview: Defining Microfluidic Organ-on-Chip Engineering Current Market Size and 2025–2030
31 May 2025
The AI Gold Rush: Unveiling Hidden Gems in the Market

The AI Gold Rush: Unveiling Hidden Gems in the Market

Artificial Intelligence is reshaping the economic landscape, with industry leaders gaining a competitive edge. Tempus AI, Inc. exemplifies AI’s impact on healthcare, using sophisticated algorithms for precision medicine advancements. Key offerings include next-generation sequencing diagnostics and predictive analytics, enhancing patient outcomes. Tempus
5 April 2025
1 2 3 12